论文部分内容阅读
Doxorubicin (Dox) as a traditional chemotherapy drugs, having significant side effects,such as cardiotoxicity, mucositis, myelosuppression [1].Meanwhile, many tumor cells also have a multi-drug resistant (MDR), resulting in lower drug concentration in the tumor cells, and reducing its therapeutic effect [2,3].